Search
for
Sort by
Research 151–180 of 876
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Coffea arabica: An Emerging Active Ingredient in Dermato-Cosmetic Applications
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Raising awareness of Demodex mites: a neglected cause of skin disease
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Type 2 Diabetes Mellitus and Demodex folliculorum Infestation: A Cross-Sectional Study in Peruvian Patients
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Redefining hair restoration with instant results – Is bio-enhanced simultaneous transplant long hair FUE the future?
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- A systematic review and meta‐synthesis of qualitative studies of alopecia: Managing identity and appearance changes
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Identification and characterization of alopecia areata subgroups regarding quality of life impairment based on demographic, clinical, psychological, and social factors
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey
- Multi-omics analysis of functional substances and expression verification in cashmere fineness
- Establishing the financial burden of alopecia areata and its predictors
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials